drugset / Trial / NCT01618929

Effects of Montelukast in Asthmatic Children With and Without Food Allergy

NCT01618929

RandomizedCrossoverQuadruple-blindTreatment

Summary

* To search the effects of montelukast on the airway inflammation including FEV1%, FEV1%/FVC, the provocholine® (methacoline chloride powder for inhalation) challenge tests, the leukotriene levels in the exhaled breath condensate in asthmatic children with and without food allergy aged 6-18 years old. * To define the patient groups with good response to montelukast and to define the parameters which predict the good response.

Timeline

Start
2013-03
Primary completion
2015-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 5 mg
Comparator Montelukast Other / unclassified 10 mg

Indications